Schizophrenia is a disorder of the brain that affects approximately 1% of the world’s population. Symptoms usually consist of auditory hallucinations, delusions, disorganized thoughts and behavior, and impairment of usual social and recreational activities. Most people with schizophrenia will develop symptoms for the first time in their 20’s. Men tend to have an earlier onset than women. The severity can range from mild to completely disabling. The mainstay of treatment currently involves use of antipsychotic medications in combination with psychological and social supports.
Suicide is a complication of schizophrenia in about 10% of patients, and substance abuse occurs in 50%.
TMS is being successfully used to treat some of the symptoms associated with schizophrenia. Auditory hallucinations have been shown to be reduced with TMS, and other symptoms such as social withdrawal have been ameliorated as well.
*At this time, TMS is not FDA-aproved for the treatment of Schizophrenia, which would be considered an off-label application.